Leerink Bumps PT on Exelixis (EXEL) Up to $16 Following Latest Cabozantinib Data

Go back to Leerink Bumps PT on Exelixis (EXEL) Up to $16 Following Latest Cabozantinib Data
Exelixis, Inc. (NASDAQ: EXEL) Delayed: 58.28 +1.06 (1.85%)
Previous Close $57.22    52 Week High $17.00 
Open $57.65    52 Week Low $3.55 
Day High $59.09    P/E N/A 
Day Low $57.33    EPS $-1.33 
Volume 885,420